These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2802114)

  • 1. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.
    Müller U; Helbling A; Bischof M
    Allergy; 1989 Aug; 44(6):412-8. PubMed ID: 2802114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.
    Kemeny DM; MacKenzie-Mills M; Harries MG; Youlten LJ; Lessof MH
    J Allergy Clin Immunol; 1983 Oct; 72(4):376-85. PubMed ID: 6619452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The key role of IgG4 subclass antibodies in the development of protection against allergic reactions to insect stings].
    Urbanek R; Dold S
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):536-40. PubMed ID: 3773921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy.
    Devey ME; Lee SR; Richards D; Kemeny DM
    J Allergy Clin Immunol; 1989 Sep; 84(3):326-30. PubMed ID: 2778238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
    Urbanek R; Kemeny DM; Richards D
    Clin Allergy; 1986 Jul; 16(4):317-22. PubMed ID: 3742787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of IgG and IgG4 antibodies to bee venom phospholipase A2 by competitive inhibition in ELISA.
    Rieben R; Blaser K
    J Immunol Methods; 1989 Apr; 119(1):1-8. PubMed ID: 2708823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
    Wüthrich B; Arrendal H; Lanner A
    Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological studies on bee-keepers: specific IgG and subclass typing IgG against bee venom and bee venom components.
    Urbanek R; Forster J; Ziupa J; Karitzky D
    Klin Wochenschr; 1980 Nov; 58(22):1257-60. PubMed ID: 7464005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of IgG and IgE antibody levels to honey bee venom allergens with protection to sting challenge.
    Hoffman DR; Gillman SA; Cummins LH; Kozak PP; Oswald A
    Ann Allergy; 1981 Jan; 46(1):17-23. PubMed ID: 6257151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy.
    Kemeny DM; Harries MG; Youlten LJ; Mackenzie-Mills M; Lessof MH
    J Allergy Clin Immunol; 1983 May; 71(5):505-14. PubMed ID: 6601672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honeybee venom allergy: immunoblot studies in allergic patients after immunotherapy and before sting challenge.
    Jeep S; Paul M; Müller U; Kunkel G
    Allergy; 1996 Aug; 51(8):540-6. PubMed ID: 8874657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of specific IgG antibodies in insect sting allergy.
    Urbanek R; Forster J; Karitzky D; Ziupa J
    Eur J Pediatr; 1981 Mar; 136(1):31-4. PubMed ID: 7215389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and immunological studies of beekeepers.
    Light WC; Reisman RE; Wypych JI; Arbesman CE
    Clin Allergy; 1975 Dec; 5(4):389-95. PubMed ID: 1053439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom.
    Busse WW; Reed CE; Lichtenstein LM; Reisman RE
    JAMA; 1975 Mar; 231(11):1154-6. PubMed ID: 1172815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of bee venom immunotherapy in children and adolescents.
    Urbanek R; Forster J; Kuhn W; Ziupa J
    J Pediatr; 1985 Sep; 107(3):367-71. PubMed ID: 4032132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.
    Wetterwald A; Skvaril F; Müller U; Blaser K
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):195-7. PubMed ID: 4008074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
    Ruiz B; Serrano P; Moreno C
    J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis.
    van der Linden PW; Hack CE; Struyvenberg A; van der Zwan JK
    J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):151-9. PubMed ID: 8064067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in IgG and IgE antibody levels to bee venom during immunotherapy.
    Ferrante A; Mocatta F; Goh DH
    Int Arch Allergy Appl Immunol; 1986; 81(3):284-7. PubMed ID: 3770979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.